Trial Profile
Pharmacokinetics and pharmacodynamics of ticagrelor +/- heparin in volunteers
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 21 Mar 2013
Price :
$35
*
At a glance
- Drugs Ticagrelor (Primary) ; Heparin
- Indications Acute coronary syndromes; Coronary artery disease; Embolism and thrombosis; Peripheral arterial disorders
- Focus Pharmacodynamics; Pharmacokinetics
- Sponsors AstraZeneca
- 21 Mar 2013 New trial record